KMB

MKT CAP:$32B

Kimberly-Clark Corporation

Market Cap

$32B

Consumer Defensive·Household & Personal Products·🇺🇸 United States·NASDAQ

Consumer Def.·Household·🇺🇸·NASDAQ

Stock Price

$97.52-$3.89 (-3.83%)

Apr 24, 2026

Company Details

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products worldwide. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The Persona...

CEO

Michael D. Hsu

IPO Date

Mar 17, 1980

Website

www.kimberly-clark.com

Key Metrics TTM

Revenue

$19.4B

+2.0% YoY

Net Income

$2.0B

EPS (Diluted)

$5.97

Free Cash Flow

$2.4B

Revenue / Share

$57.26

Gross Margin

33.2%

Operating Margin

13.3%

Net Margin

10.4%

FCF Margin

12.6%

P/S

1.7x

P/E

16.1x

Earnings Reports

Q3 2024

Apr 28, 2026

PENDING

Q2 2024

Jul 23, 2024

$4.2BEPS $1.61

Q1 2024

Apr 23, 2024

$5.1BEPS $1.91

FY 2023

Feb 8, 2024

$20.4BEPS $5.21

Q4 2021

Feb 10, 2022

$5.0B+2.7%EPS $1.06

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q3 18	$4.6B	$1.4B	$669M
Q4 18	$4.6B	$1.4B	$639M
Q1 19	$4.6B	$1.4B	$655M
Q2 19	$4.6B	$1.5B	$670M
Q3 19	$4.6B	$1.6B	$915M
Q4 19	$4.6B	$1.6B	$751M
Q1 20	$5.0B	$1.8B	$904M
Q2 20	$4.6B	$1.8B	$925M
Q3 20	$4.7B	$1.6B	$666M
Q4 20	$4.8B	$1.7B	$749M
Q1 21	$4.7B	$1.6B	$770M
Q2 21	$4.7B	$1.5B	$613M
Q3 21	$5.0B	$1.5B	$657M
Q4 21	$5.0B	$1.4B	$521M
Q1 24	$5.1B	$1.9B	$853M
Q2 24	$4.2B	$1.6B	$539M

Valuation

Quarter	P/S	P/E
Q3 18	2.1x	24.3x
Q4 18	2.1x	27.8x
Q1 19	2.3x	23.9x
Q2 19	2.5x	25.9x
Q3 19	2.6x	24.0x
Q4 19	2.5x	21.7x
Q1 20	2.4x	19.1x
Q2 20	2.5x	18.6x
Q3 20	2.7x	21.3x
Q4 20	2.4x	19.3x
Q1 21	2.5x	20.6x
Q2 21	2.3x	22.3x
Q3 21	2.3x	22.3x
Q4 21	2.5x	26.5x
Q1 24	2.2x	23.1x
Q2 24	2.4x	22.9x

Operating Cash Flow

Quarter	Operating CF	Free CF
Q3 18	$692M	$473M
Q4 18	$949M	$638M
Q1 19	$317M	$1M
Q2 19	$609M	$356M
Q3 19	$886M	$588M
Q4 19	$924M	$582M
Q1 20	$704M	$352M
Q2 20	$1.6B	$1.3B
Q3 20	$559M	$301M
Q4 20	$887M	$564M
Q1 21	$321M	$23M
Q2 21	$565M	$364M
Q3 21	$782M	$547M
Q4 21	$1.1B	$789M
Q1 24	$438M	$244M
Q2 24	$1.0B	$863M

Capital Expenditures

Quarter	CapEx
Q3 18	$219M
Q4 18	$311M
Q1 19	$316M
Q2 19	$253M
Q3 19	$298M
Q4 19	$342M
Q1 20	$352M
Q2 20	$284M
Q3 20	$258M
Q4 20	$323M
Q1 21	$298M
Q2 21	$201M
Q3 21	$235M
Q4 21	$273M
Q1 24	$194M
Q2 24	$158M

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q3 18	-1.3%	+3.7%
Q4 18	-0.3%	+4.2%
Q1 19	-2.1%	-11.3%
Q2 19	-0.2%	-0.2%
Q3 19	+1.3%	-4.8%
Q4 19	+0.3%	-2.5%
Q1 20	+8.1%	+3.2%
Q2 20	+0.4%	-6.0%
Q3 20	+0.9%	+7.8%
Q4 20	+5.5%	+6.7%
Q1 21	-5.3%	-3.2%
Q2 21	+2.4%	+11.4%
Q3 21	+7.0%	+8.4%
Q4 21	+2.7%	+8.7%
Q1 24	+8.6%	+8.1%
Q2 24	-10.4%	-10.1%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q3 18	$19M	0.4%
Q4 18	-$4M	-0.1%
Q1 19	$16M	0.3%
Q2 19	$32M	0.7%
Q3 19	$26M	0.6%
Q4 19	$22M	0.5%
Q1 20	$15M	0.3%
Q2 20	$39M	0.8%
Q3 20	$47M	1.0%
Q4 20	$46M	1.0%
Q1 21	$22M	0.5%
Q2 21	$20M	0.4%
Q3 21	-$12M	-0.2%
Q4 21	-$4M	-0.1%
Q1 24	$32M	0.6%
Q2 24	$39M	0.9%

OpEx Breakdown

Quarter	R&D	G&A	SG&A
Q3 18	—	$749M	—
Q4 18	$317M	$768M	—
Q1 19	—	$769M	—
Q2 19	—	$811M	—
Q3 19	—	$815M	—
Q4 19	$284M	$859M	—
Q1 20	—	—	$850M
Q2 20	—	—	$844M
Q3 20	—	—	$919M
Q4 20	$276M	—	$962M
Q1 21	—	—	$815M
Q2 21	—	—	$854M
Q3 21	—	—	$819M
Q4 21	$269M	—	$876M
Q1 24	—	—	$1.0B
Q2 24	—	—	$967M

Revenue Segments

Quarter	Consumer Tissue	K-C Professional	Personal Care
Q3 18	$1.5B	$848M	$2.3B
Q4 18	$1.5B	$841M	$2.2B
Q1 19	$1.5B	$817M	$2.3B
Q2 19	$1.5B	$821M	$2.3B
Q3 19	$1.5B	$839M	$2.3B
Q4 19	$1.5B	$815M	$2.2B
Q1 20	$1.7B	$848M	$2.4B
Q2 20	$1.6B	$724M	$2.2B
Q3 20	$1.6B	$705M	$2.3B
Q4 20	$1.7B	$742M	$2.3B
Q1 21	$1.5B	$752M	$2.5B
Q2 21	$1.4B	$765M	$2.5B
Q3 21	$1.5B	$797M	$2.7B
Q4 21	$1.6B	$758M	$2.6B
Q1 24	$1.6B	$823M	$2.7B

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 22	$493M	$0	$493M
Q2 22	$311M	$0	$311M
Q3 22	$362M	$0	$362M
Q4 22	$427M	$0	$427M
Q1 23	$524M	$0	$524M
Q2 23	$580M	$0	$580M
Q3 23	$814M	$0	$814M
Q4 23	$1.1B	$0	$1.1B
Q1 24	$853M	$0	$853M
Q2 24	$1.2B	$0	$1.2B
Q3 24	$1.1B	$0	$1.1B
Q4 24	$1.0B	$0	$1.0B
Q1 25	$563M	$0	$563M
Q2 25	$634M	$0	$634M
Q3 25	$617M	$0	$617M
Q4 25	$688M	$0	$688M

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q3 18	349M	-0.4%	-1.7%
Q4 18	347M	-0.4%	-1.7%
Q1 19	344M	-1.0%	-2.5%
Q2 19	346M	+0.6%	-1.2%
Q3 19	346M	-0.0%	-0.8%
Q4 19	344M	-0.4%	-0.8%
Q1 20	344M	-0.1%	+0.1%
Q2 20	342M	-0.6%	-1.2%
Q3 20	342M	+0.1%	-1.0%
Q4 20	341M	-0.4%	-1.0%
Q1 21	339M	-0.5%	-1.4%
Q2 21	338M	-0.3%	-1.1%
Q3 21	338M	-0.2%	-1.4%
Q4 21	338M	+0.2%	-0.9%
Q1 24	338M	+0.0%	-0.3%
Q2 24	338M	-0.1%	-0.1%

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q3 18	$109.1K	42K
Q4 18	$111.4K	41K
Q1 19	$113.0K	41K
Q2 19	$112.0K	41K
Q3 19	$113.2K	41K
Q4 19	$114.6K	40K
Q1 20	$125.2K	40K
Q2 20	$115.3K	40K
Q3 20	$117.1K	40K
Q4 20	$105.1K	46K
Q1 21	$103.1K	46K
Q2 21	$102.7K	46K
Q3 21	$108.9K	46K
Q4 21	$110.3K	45K
Q1 24	$125.6K	41K
Q2 24	$103.2K	41K

Revenue / Employee